Gene · 871
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Balanced diets are associated with a lower risk of type 2 diabetes than plant-based diets. | Diabetes Res Clin Pract | 2025 | 39736334 | PubTator, text mining | PubMed |
| Microfocused Ultrasound With Visualization Induces Remodeling of Collagen and Elastin Within the Skin. | J Cosmet Dermatol | 2025 | 39545626 | PubTator, text mining | PubMed |
| SERPINH1 as a Novel Biomarker for Colon Cancer Bone Metastasis with Machine Learning and Immunohistochemistry Validation. | Cancer Biother Radiopharm | 2025 | 39422029 | PubTator, text mining | PubMed |
| Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis. | Pharm Sci Adv | 2024 | 41550179 | PubTator, text mining | PubMed |
| Investigation of ITGB3 Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer. | Biology (Basel) | 2024 | 39857240 | PubTator, text mining | PubMed |
| Geranylgeranyl Pyrophosphate Promotes Profibrotic Factors and Collagen-Specific Chaperone HSP47 in Fibroblasts. | J Cell Mol Med | 2024 | 39716037 | PubTator, text mining | PubMed |
| Dextromethorphan inhibits collagen and collagen-like cargo secretion to ameliorate lung fibrosis. | Sci Transl Med | 2024 | 39693409 | PubTator, text mining | PubMed |
| Proteomics analysis of body fluid exosomes of rheumatoid arthritis patients underwent oxhorn cupping therapy. | PLoS One | 2024 | 39666600 | PubTator, text mining | PubMed |
| Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer. | Adv Sci (Weinh) | 2024 | 39488790 | PubTator, text mining | PubMed |
| Physics of fractional microneedle radiofrequency - A review. | J Cutan Aesthet Surg | 2024 | 39483649 | PubTator, text mining | PubMed |
| Downregulation of heat shock protein 47 caused lysosomal dysfunction leading to excessive chondrocyte apoptosis. | Exp Cell Res | 2024 | 39447624 | PubTator, text mining | PubMed |
| Integrated analysis of tumor and adjacent non-tumor proteomic data reveals SERPINH1 as a recurrence biomarker and drug target in hepatocellular carcinoma. | Int J Biol Sci | 2024 | 39430252 | PubTator, text mining | PubMed |
| Mutations in fibronectin dysregulate chondrogenesis in skeletal dysplasia. | Cell Mol Life Sci | 2024 | 39367925 | PubTator, text mining | PubMed |
| Identification of New Potential Targets for Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatic Analysis. | Anticancer Res | 2024 | 39348994 | PubTator, text mining | PubMed |
| Proteomic Heterogeneity of the Extracellular Matrix Identifies Histologic Subtype-Specific Fibroblast in Gastric Cancer. | Mol Cell Proteomics | 2024 | 39305996 | PubTator, text mining | PubMed |
| Molecular characterization, immunocorrelation analysis, WGCNA analysis and machine learning modeling of genes associated with copper death subtypes of laryngeal cancer. | Technol Health Care | 2024 | 39302398 | PubTator, text mining | PubMed |
| Mapping variants in HTLV-1 genome to analyze their impacts on the HAM/TSP development: A systematic review. | J Med Virol | 2024 | 39279426 | PubTator, text mining | PubMed |
| Structural insights into the biosynthetic mechanism of Nα-GlyT and 5-NmdU hypermodifications of DNA. | Nucleic Acids Res | 2024 | 39268585 | PubTator, text mining | PubMed |
| SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancer. | iScience | 2024 | 39161960 | PubTator, text mining | PubMed |
| HSP47 in human diseases: Navigating pathophysiology, diagnosis and therapy. | Clin Transl Med | 2024 | 39135385 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/papers?page=8